For stable PLCG1 overexpression (SW48-PLCG1), SW48 cells were infected with PLCG1 lentiviral activation particles (Santa Cruz Biotechnology). Selection of stable clones started 2 days after infection with a mix of 2 ?g/mL Puromycin, 50 mg/mL Hygromicyn B, and 10 mg/mL Blasticidin.
Gender:
Male
CRISPR:
No
Parental cell line:
SW480
Disease:
Cancer
Cat. #:
161945
Cancer types:
Colorectal cancer
Research Fields:
Cancer
Organism:
Human
Tissue:
Epithelial
Gender:
Male
Model:
Over-expression
Growth properties:
A subcultivation ratio of 1:4 to 1:6 is recommended, 1 to 2 times per week.
Primary citation:
Martins, et al. 2022. Clin Cancer Res. 28(6):1203-1216. PMID: 34980600
Format:
Frozen
Storage conditions:
Liquid Nitrogen
Shipping conditions:
Dry Ice
Growth medium:
DMEM with 10% FBS, 5% CO2
Recommended controls:
shRNA scrambled control
Biosafety level:
1
References:
Martins, et al. 2022. Clin Cancer Res. 28(6):1203-1216. PMID: 34980600
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.